ASN shapes federal policies, increases federal and institutional resources, and influences regulatory directives to help its members. https://www.asn-online.org/policy/ en-us Copyright 2026 Sat, 14 Mar 2026 11:53:28 GMT Sat, 14 Mar 2026 11:53:28 GMT http://blogs.law.harvard.edu/tech/rss hnesbitt@asn-online.org (Hal Nesbitt) https://www.asn-online.org/images/_global/apple-touch-icon.png https://www.asn-online.org/policy/ https://epc.asn-online.org/projects/epr/ frontID=290 ASN released new practical resources to help safeguard patients in high-risk situations, including emergency information cards for patients with kidney failure and kidney transplants, as well as a clinician-focused FAQ for patients living with kidney failure in or at risk of detention. These tools are meant to equip nephrologists with clear information to support continuity of life-sustaining care, facilitate timely communication, and clarify patients'' medical and legal needs. Wed, 11 Mar 2026 14:38:44 GMT https://www.asn-online.org/policy/webdocs/ASN_LOS_KSN_pdf.pdf frontID=289 ASN voices full support for the "Chronic Kidney Disease (CKD) Management Act" of the Republic of Korea, recognizing this legislation as a visionary step toward setting a new global standard for patient-centered renal care. ASN strongly supports the three core pillars of this Act, Global Leadership in Renal Health Policy, Commitment to Innovation and Patient-Centered Care, and Advancing Evidence-Based Medicine through a National Registry, which align with ASN's mission to lead the fight against kidney diseases. Tue, 03 Mar 2026 20:25:29 GMT https://www.asn-online.org/policy/webdocs/friends_of_ahrq_appropriations_request_fy27_1.pdf frontID=288 In a letter to Congress, ASN urged appropriators to fully fund the Agency for Healthcare Research and Quality (AHRQ) with $500 million in FY2027 in order to meet staffing needs and statutory obligations. Mon, 02 Mar 2026 20:18:02 GMT https://www.asn-online.org/policy/webdocs/26_02_25_MA_Rate_Announcement_Comments_FINAL.pdf frontID=287 In a letter to the Centers for Medicare and Medicaid Services (CMS), ASN commends the agency's proposal to refine the HCC Risk Adjustment Methodology to better account for CKD severity, while continuing to raise concerns about Medicare Advantage data collection and transparency. Wed, 25 Feb 2026 20:48:34 GMT https://www.asn-online.org/policy/webdocs/26_2_9_FINAL_ASN_IOTA_Comments.pdf frontID=286 ASN submitted robust comments and made key recommendations to the Centers for Medicare and Medicaid Innovation (CMMI) regarding updates to the Increasing Organ Transplant Access (IOTA) Model. Tue, 10 Feb 2026 21:00:22 GMT https://www.asn-online.org/policy/webdocs/PTAC_Improving_MultiPayer_Alignment_in_Value_Based_Care_RFI_Comment_Letter_FINAL.pdf frontID=284 ASN submitted comments addressing seven questions posed by the Physician-Focused Payment Model Technical Advisory Committee (PTAC) as part of its Improving Multi-Payer Alignment in Value-Based Care Request for Input. Fri, 30 Jan 2026 22:02:35 GMT https://www.asn-online.org/policy/webdocs/CY2027_Medicare_Advantage_Comment_Letter_Final.pdf frontID=283 ASN submitted comments to CMS Administrator Oz in response to the CY2027 policy and technical changes to the Medicare Advantage program. The comments addressed specific rule changes and their potential impact on care for patients with kidney disease. Wed, 28 Jan 2026 15:09:10 GMT https://www.asn-online.org/policy/webdocs/Community_Appropriations_Sign_on_Letter_FINAL.pdf frontID=282 In a letter to Congressional leadership, ASN urged leaders to pass a final appropriations bill that provides at least $48.7 billion for NIH in fiscal year 2026. Wed, 28 Jan 2026 14:54:12 GMT https://www.asn-online.org/policy/webdocs/12_16_25_Fall_Battelle_EM_Comment_Letter_final.pdf frontID=281 ASN submitted a PQM Fall 2025 Endorsement and Maintenance (E&M) Comment Letter addressing ESRD facility-level measures up for maintenance and endorsement. ASN expressed concern and offered suggestions to CMS, urging feedback to be taken into consideration to improve the care provided to individual patients. Wed, 17 Dec 2025 19:44:12 GMT https://www.researchamerica.org/wp-content/uploads/2025/12/FY2026-ARPA-H-Sign-On-Letter-12-11-25.pdf frontID=280 ASN urged members of the Senate Appropriations Committee to provide at least $1.5 billion funding for Advanced Research Projects Agency for Health (ARPA-H). Since 2022, ARPA-H has focused on high-risk, high-reward, end-product-driven research and development to accelerate health breakthroughs. It is crucial that this momentous work continue to deliver results and supplement the work of NIH and other health-related agencies through innovation. Wed, 17 Dec 2025 15:26:51 GMT